WARREN, R.; SOFEN, H.; IMAFUKU, S.; SZEPIETOWSKI, J.; BLAUVELT, A.; SPELMAN, L.; TOMS, J.; BUCK, A.; BANERJEE, S.; MENTER, A. Deucravacitinib long-term efficacy and safety in plaque psoriasis: 2-year results from the phase 3 POETYK PSO program. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s48, 2022. DOI: 10.25251/skin.6.supp.48. Disponível em: https://jofskin.org/index.php/skin/article/view/1803. Acesso em: 3 jul. 2024.